Last reviewed · How we verify
NCT07522268
Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy
Phase 3 trial testing Group B (Diode Laser) in Pulpotomy in 84 participants. Completed in 1 January 2021.
1 January 2021
Quick facts
| Lead sponsor | Shaheed Zulfiqar Ali Bhutto Medical University |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 84 |
| Start date | 1 June 2019 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Group B (Diode Laser)
- (Ferric Sulphate)
Conditions studied
- Pulpotomy — all drugs for Pulpotomy →
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Who can join
Adults 4 to 8, any sex, with Pulpotomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diode lasers could be a viable alternative to ferric sulphate in pulpotomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07522268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulpotomy
Currently open trials in the same condition.
- NCT06685640 — Comparison of Clinical Success of Stainless Steel Crowns and Zirconia Crowns in Primary Molars · NA · recruiting
- NCT06288477 — Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Biocera · NA · recruiting
- NCT06640205 — Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars · NA · recruiting
- NCT04863222 — Clinical and Radiographic Success of MTA vs Biodentine · Phase 4 · recruiting
- NCT02298504 — Vital Pulp Treatment in Primary Teeth · Phase 4 · active not recruiting
Other Shaheed Zulfiqar Ali Bhutto Medical University trials
Trials by the same sponsor.
- NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis · NA · recruiting
- NCT06176430 — Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy · Phase 4 · unknown
- NCT06234020 — Frequency of Vertebrospinal Anomalies in Patients Presenting With Anorectal Malformations · completed
- NCT06323642 — Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Ped · NA · unknown
- NCT06164158 — Role of Procedural Videos in Teaching the Surgery Residents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07522268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shaheed Zulfiqar Ali Bhutto Medical University
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07522268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing